| Medical Mutual | Enhanced Oncology Value: Loqtorzi® (toripalimab-tpzi) (Intravenous) (EOV) | 2026-07-01 |
| Medical Mutual | Penpulimab-KCQX (penpulimab-kcqx) (Intravenous) | 2026-07-01 |
| Medical Mutual | Qalsody® (tofersen) (Intrathecal) | 2026-07-01 |
| Medical Mutual | Radicava® (edaravone) (Intravenous) | 2026-07-01 |
| Medical Mutual | Tecentriq Hybreza® (atezolizumab and hyaluronidase-tqjs) | 2026-07-01 |
| Medical Mutual | Oncology Value: Tecentriq® (atezolizumab) (Intravenous) (EOV) | 2026-07-01 |
| Medical Mutual | Oncology Value: Tecvayli® (teclistamab-cqyv) (Subcutaneous) | 2026-07-01 |
| Medical Mutual | Tevimbra® (tislelizumab-jsgr) (Intravenous) (EOV) | 2026-07-01 |
| Medical Mutual | Value: Tzield® (teplizumab-mzwv) (Intravenous) | 2026-07-01 |
| Medical Mutual | Oncology Value: Unloxcyt™ (cosibelimab-ipdl) (Intravenous) (EOV) | 2026-07-01 |